Showing codes 69097-420-21 Celecoxib — 69097-445-02 Atazanavir

69097-420-21 - Celecoxib
Firm: Cipla USA Inc.
Package Description: 10 BLISTER PACK in 1 CARTON (69097-420-21) / 10 CAPSULE in 1 BLISTER PACK (69097-420-19)
Usage type: ORAL
HTML  TXT

69097-421-02 - Celecoxib
Firm: Cipla USA Inc.
Package Description: 30 CAPSULE in 1 BOTTLE (69097-421-02)
Usage type: ORAL
HTML  TXT

69097-421-07 - Celecoxib
Firm: Cipla USA Inc.
Package Description: 100 CAPSULE in 1 BOTTLE (69097-421-07)
Usage type: ORAL
HTML  TXT

69097-421-12 - Celecoxib
Firm: Cipla USA Inc.
Package Description: 500 CAPSULE in 1 BOTTLE (69097-421-12)
Usage type: ORAL
HTML  TXT

69097-421-21 - Celecoxib
Firm: Cipla USA Inc.
Package Description: 10 BLISTER PACK in 1 CARTON (69097-421-21) / 10 CAPSULE in 1 BLISTER PACK (69097-421-19)
Usage type: ORAL
HTML  TXT

69097-422-02 - Celecoxib
Firm: Cipla USA Inc.
Package Description: 30 CAPSULE in 1 BOTTLE (69097-422-02)
Usage type: ORAL
HTML  TXT

69097-422-07 - Celecoxib
Firm: Cipla USA Inc.
Package Description: 100 CAPSULE in 1 BOTTLE (69097-422-07)
Usage type: ORAL
HTML  TXT

69097-422-12 - Celecoxib
Firm: Cipla USA Inc.
Package Description: 500 CAPSULE in 1 BOTTLE (69097-422-12)
Usage type: ORAL
HTML  TXT

69097-422-21 - Celecoxib
Firm: Cipla USA Inc.
Package Description: 10 BLISTER PACK in 1 CARTON (69097-422-21) / 10 CAPSULE in 1 BLISTER PACK (69097-422-19)
Usage type: ORAL
HTML  TXT

69097-423-02 - Celecoxib
Firm: Cipla USA Inc.
Package Description: 30 CAPSULE in 1 BOTTLE (69097-423-02)
Usage type: ORAL
HTML  TXT

69097-423-03 - Celecoxib
Firm: Cipla USA Inc.
Package Description: 60 CAPSULE in 1 BOTTLE (69097-423-03)
Usage type: ORAL
HTML  TXT

69097-425-02 - Entecavir
Firm: Cipla USA Inc.
Package Description: 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69097-425-02)
Usage type: ORAL
HTML  TXT

69097-426-02 - Entecavir
Firm: Cipla USA Inc.
Package Description: 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69097-426-02)
Usage type: ORAL
HTML  TXT

69097-426-05 - Entecavir
Firm: Cipla USA Inc.
Package Description: 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69097-426-05)
Usage type: ORAL
HTML  TXT

69097-429-67 - Nypozi
Firm: Cipla USA Inc.
Package Description: 1 SYRINGE, GLASS in 1 CARTON (69097-429-67) / 480 ug in 1 SYRINGE, GLASS
Usage type: INTRAVENOUS; SUBCUTANEOUS
HTML  TXT

69097-429-96 - Nypozi
Firm: Cipla USA Inc.
Package Description: 10 SYRINGE, GLASS in 1 CARTON (69097-429-96) / 480 ug in 1 SYRINGE, GLASS
Usage type: INTRAVENOUS; SUBCUTANEOUS
HTML  TXT

69097-430-67 - Nypozi
Firm: Cipla USA Inc.
Package Description: 1 SYRINGE, GLASS in 1 CARTON (69097-430-67) / 300 ug in 1 SYRINGE, GLASS
Usage type: INTRAVENOUS; SUBCUTANEOUS
HTML  TXT

69097-430-96 - Nypozi
Firm: Cipla USA Inc.
Package Description: 10 SYRINGE, GLASS in 1 CARTON (69097-430-96) / 300 ug in 1 SYRINGE, GLASS
Usage type: INTRAVENOUS; SUBCUTANEOUS
HTML  TXT

69097-431-02 - Darifenacin
Firm: Cipla USA Inc.
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-431-02)
Usage type: ORAL
HTML  TXT

69097-431-05 - Darifenacin
Firm: Cipla USA Inc.
Package Description: 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-431-05)
Usage type: ORAL
HTML  TXT

69097-431-15 - Darifenacin
Firm: Cipla USA Inc.
Package Description: 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-431-15)
Usage type: ORAL
HTML  TXT

69097-432-02 - Darifenacin
Firm: Cipla USA Inc.
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-432-02)
Usage type: ORAL
HTML  TXT

69097-432-05 - Darifenacin
Firm: Cipla USA Inc.
Package Description: 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-432-05)
Usage type: ORAL
HTML  TXT

69097-432-15 - Darifenacin
Firm: Cipla USA Inc.
Package Description: 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-432-15)
Usage type: ORAL
HTML  TXT

69097-438-02 - Sertraline Hydrochloride
Firm: Cipla USA Inc.
Package Description: 30 CAPSULE in 1 BOTTLE (69097-438-02)
Usage type: ORAL
HTML  TXT

69097-439-35 - Palonosetron Hydrochloride
Firm: Cipla USA Inc.
Package Description: 1 VIAL, SINGLE-USE in 1 CARTON (69097-439-35) / 5 mL in 1 VIAL, SINGLE-USE
Usage type: INTRAVENOUS
HTML  TXT

69097-443-02 - Atazanavir
Firm: Cipla USA Inc.
Package Description: 30 CAPSULE, GELATIN COATED in 1 BOTTLE (69097-443-02)
Usage type: ORAL
HTML  TXT

69097-443-03 - Atazanavir
Firm: Cipla USA Inc.
Package Description: 60 CAPSULE, GELATIN COATED in 1 BOTTLE (69097-443-03)
Usage type: ORAL
HTML  TXT

69097-444-02 - Atazanavir
Firm: Cipla USA Inc.
Package Description: 30 CAPSULE, GELATIN COATED in 1 BOTTLE (69097-444-02)
Usage type: ORAL
HTML  TXT

69097-444-03 - Atazanavir
Firm: Cipla USA Inc.
Package Description: 60 CAPSULE, GELATIN COATED in 1 BOTTLE (69097-444-03)
Usage type: ORAL
HTML  TXT

69097-445-02 - Atazanavir
Firm: Cipla USA Inc.
Package Description: 30 CAPSULE, GELATIN COATED in 1 BOTTLE (69097-445-02)
Usage type: ORAL
HTML  TXT